General American Investors’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-450,000
Closed -$1.08M 77
2023
Q3
$1.08M Hold
450,000
0.1% 65
2023
Q2
$1.04M Hold
450,000
0.09% 61
2023
Q1
$1.15M Hold
450,000
0.11% 58
2022
Q4
$1.13M Buy
450,000
+50,000
+13% +$140K 0.11% 55
2022
Q3
$1.16M Buy
400,000
+364,123
+1,015% +$1.53M 0.12% 57
2022
Q2
$162K Buy
+35,877
New +$213K 0.02% 60

Other funds holding SLGC

General American Investors's SLGC Position: Q4 2023 in Review

General American Investors sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q4 2023, closing a stake of 450,000 shares — an estimated $1.08M sold.

General American Investors first reported a position in SLGC in Q2 2022 and held it in 6 quarters. The position peaked at $1.16M in Q3 2022. 119 funds tracked by Wall St. Rank hold SLGC as of Q4 2023.

  • General American Investors reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q4 2023 after selling out during the quarter.
  • General American Investors sold 450,000 SomaLogic, Inc. Class A Common Stock shares in Q4 2023, an estimated $1.08M.
  • General American Investors first reported a position in SomaLogic, Inc. Class A Common Stock in Q2 2022 and held it in 6 quarters.
  • General American Investors's SomaLogic, Inc. Class A Common Stock position peaked at $1.16M in Q3 2022.
  • 119 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q4 2023.

Based on General American Investors's 13F filing for Q4 2023, filed 13 Feb 2024.